EAN 2020 | Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?

Name: Alzheimer’s disease: what are the challenges when disease-modifying therapies become available?
Uploaded: 2020-05-26T00:00:00Z
Duration: 4 min 30 s
Description: Paola Barbarino, CEO, Alzheimer's Disease International, outlines the challenges to prepare healthcare systems for the diagnosis, treatment, and care of Alzheimer's disease in a future with disease-modifying therapies. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).

Paola Barbarino • 26 May 2020

EAN 2020

Alzheimer’s Disease Dementia

Paola Barbarino, CEO, Alzheimer’s Disease International, outlines the challenges to prepare healthcare systems for the diagnosis, treatment, and care of Alzheimer’s disease in a future with disease-modifying therapies. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).